Kissei Pharmaceutical Co., Ltd.

Yasushi Nakano

Makio Kitazawa

Masuo Akahane

Michihiro Kobayashi

Atsushi Tsubaki

Masaaki Ban

Kazuaki Sato

Ryoji Yamamoto

Tsutomu Tsukamoto

The present invention provides a novel class of naphthylsulfonylalkanoic acid compounds such as a structure corrresponding to the formula: ##STR1## or a pharmaceutically acceptable salt thereof. A present invention naphthylsulfonylalkanoic acid compound is useful for prevention or treatment of irritable bowel syndrome, biliary dyskinesia and acute pancreatitis.

Naphthysulfonylalkanoic acid compounds and pharmaceutical compositions

The present invention provides a novel class of phenylsulfonylalkanoic acid compounds such as a structure corresponding to the formula: ##STR1## or a pharmaceutically acceptable salt thereof. A present invention phenylsulfonylalkanoic acid compound is useful for prevention or treatment of irritable bowel syndrome, biliary dyskinesia and acute pancreatitis.

Phenylsulfonylalkanoic acid compounds and pharmaceuticals thereof

This invention provides novel isatin compounds which are useful as therapeutic agents. The invention isatin compounds and the pharmaceutically acceptable salts thereof exhibit anti-ulcer activities which are applicable for propylaxis and treatment of ulcer diseases in the digestive tract of animals.

Isatin compositions having anti-ulcer activities

Growing community of inventors

Shiojiri, Japan

Yasushi Nakano